<DOC>
	<DOC>NCT00532922</DOC>
	<brief_summary>The purpose of this study is to investigate real practices of treatment with Symbicort Turbuhaler for 3 months in asthma and patient compliance.</brief_summary>
	<brief_title>A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®</brief_title>
	<detailed_description />
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>1. Provision of informed consent 2. Asthmatics who has been prescribed Symbicort according to physician's judgement 3. Usage of Symbicort should follow local prescribing information 1. Not being involved in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site) 2. No previous enrolment in the present study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>